Chuanqi Wei

Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments

Chuanqi Wei, Wentao Ni, Xuejiu Cai et al. · PLoS ONE · 2016 · 84 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by<i>Stenotrophomonas maltophilia</i>

Chuanqi Wei, Wentao Ni, Xuejiu Cai et al. · Infectious Diseases · 2015 · 37 citations

Pharmacy, Infectious Diseases, Pharmacology +16

Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model

Xuejiu Cai, Zhen Yang, Jianqiang Dai et al. · International Journal of Antimicrobial Agents · 2017 · 32 citations

Life Sciences, Infectious Diseases, Pharmacology +14

Diagnostic Value of the Serum Galactomannan and (1, 3)-β-D-glucan Assays for Invasive Pulmonary Aspergillosis in Non-neutropenic Patients

Xuejiu Cai, Wentao Ni, Chuanqi Wei et al. · Internal Medicine · 2014 · 24 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae

Wentao Ni, Chuanqi Wei, Jin Feng Zhao et al. · Frontiers in Microbiology · 2016 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17